Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk

Tahan V., Canbakan B., Balci H., Dane F., Akin H., Can G., ...Daha Fazla

HEPATO-GASTROENTEROLOGY, cilt.55, sa.85, ss.1433-1438, 2008 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 55 Konu: 85
  • Basım Tarihi: 2008
  • Sayfa Sayıları: ss.1433-1438


Background/Aims: Hepatocyte apoptosis is an important and invasive predictor of liver injury and fibrosis in non-alcoholic fatty liver disease (NAFLD). Increased gamma-glutamyltranspeptidase (GGT) level is frequently observed in NAFLD. Hepatocyte growth factor (HGF) Stimulates fibrogenesis and is correlated with GGT. The study aimed to determine whether GGT can distinguish NAFLD) patients at high risk.